Assignee
89BIO LTD
IL·13 granted patents·7 pending applications·38 citations·filing 2015–2025
Top patents by PatentIndex Score
20 records- 0195US11702388B21,4-substituted piperidine derivatives89BIO LTD·Filed 2020·Granted Jul 18, 2023·3 cites·20 claims
- 0293US10851057B21,4-substituted piperidine derivatives89BIO LTD·Filed 2019·Granted Dec 1, 2020·5 cites·16 claims
- 0390US10221135B21,4-substituted piperidine derivatives89BIO LTD·Filed 2018·Granted Mar 5, 2019·7 cites·30 claims
- 0489US11046707B2Spiropiperidine derivatives89BIO LTD·Filed 2017·Granted Jun 29, 2021·4 cites·16 claims
- 0588US11427623B1Methods of treatment using mutant FGF-21 peptide conjugates89BIO LTD·Filed 2020·Granted Aug 30, 2022·3 cites·32 claims
- 0688US10919875B2Substituted 4-benzyl and 4-benzoyl piperidine derivatives89BIO LTD·Filed 2016·Granted Feb 16, 2021·4 cites·26 claims
- 0787US10874714B2Method of treating fibroblast growth factor 21 (FGF-21) deficiency89BIO LTD·Filed 2015·Granted Dec 29, 2020·2 cites·8 claims
- 0886US12098130B21,4-substituted piperidine derivatives89BIO LTD·Filed 2023·Granted Sep 24, 2024·0 cites·18 claims
- 0984US12448392B2Spiropiperidine derivatives89BIO LTD·Filed 2023·Granted Oct 21, 2025·0 cites·18 claims
- 1083US10407479B2Mutant FGF-21 peptide pegylated conjugates and uses thereof89BIO LTD·Filed 2018·Granted Sep 10, 2019·10 cites·27 claims
- 1173US11878982B2Spiropiperidine derivatives89BIO LTD·Filed 2021·Granted Jan 23, 2024·0 cites·2 claims
- 1271US12037376B2Methods of treatment using mutant FGF-21 peptide conjugates89BIO LTD·Filed 2022·Granted Jul 16, 2024·0 cites·36 claims
- 1371US2024116995A1Mutant fgf-21 peptide pegylated conjugates and uses thereof89BIO LTD·Filed 2023·Application pending·0 cites
- 1470US2021100876A1Method of Treating of Fibroblast Growth Factor 21 (FGF-21) Deficiency89BIO LTD·Filed 2020·Application pending·0 cites
- 1568US11878966B2Substituted 4-benzyl and 4-benzoyl piperidine derivates89BIO LTD·Filed 2021·Granted Jan 23, 2024·0 cites·1 claims
- 1666US2025333460A1Mutant fgf-21 peptide pegylated conjugates and uses thereof89BIO LTD·Filed 2025·Application pending·0 cites
- 1763US2025282840A1Methods of treatment using mutant fgf-21 peptide conjugates89BIO LTD·Filed 2025·Application pending·0 cites
- 1862US2019389921A1Mutant fgf-21 peptide pegylated conjugates and uses thereof89BIO LTD·Filed 2019·Application pending·0 cites
- 1962US2021355183A1Mutant fgf-21 peptide pegylated conjugates and uses thereof89BIO LTD·Filed 2021·Application pending·0 cites
- 2046US2023090114A1Methods for promoting weight loss89BIO LTD·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →